Moreover, decreased tumor cell proliferation was observed in the mice given the combinatory treatment, as indicated by reduced Ki67+ cells in HMB-45+ tumor areas (HMB45 is a human melanoma marker) (Figure S3). This evidence concerns the gene MKI67 and neoplasm.